Danaher Projects 2026 Revenue Growth and Anticipates Margin Expansion

Danaher Corporation projects 2026 revenue growth of 3%-6% and a 100-basis-point operating margin expansion. The Masimo acquisition is expected to expand margins and provide high single-digit returns by year five. The company anticipates a revenue impact of $75 million to $100 million from market shifts in China but remains optimistic about long-term opportunities in AI-based drug development and domestic reshoring initiatives.